Archive for category: Global Health

Information and stories about global health.

, ,

AI Health Care in Southeast Asia

AI Health Care in Southeast AsiaSoutheast Asia is a diverse and dynamic region with a population of 675 million. Southeast Asia consists of 11 countries divided into mainland and maritime Southeast Asia. Indonesia, the Philippines, Brunei, Malaysia and East Timor (Timor-Leste) are archipelagic countries. In some of these archipelagos, health care crises have persisted for a very long time. Some islands are isolated and remote, where the traditional doctor-to-patient ratio is low. Building hospitals across the scattered islands is a slow and challenging process.

However, artificial intelligence (AI) is helping address this medical challenge by transforming standard smart devices into diagnostic hubs and clinical tools instead of relying solely on the construction of physical infrastructure. Local health care workers are utilizing low-cost, AI-integrated handheld devices and natural language processing platforms to conduct clinical screening and triage at the doorstep. AI-powered health care in Southeast Asia is serving as a modern solution to these challenges.

Handheld Diagnostics

Portable handheld devices are actively reducing the need for heavy and expensive hospital equipment and machines. Clarius Ultrasound is a transportable imaging tool that is improving the workflow of community health workers. It is a wireless handheld ultrasound scanner that can be connected to a smartphone. These scanners are cordless, which makes them easy to sanitize and carry anywhere. In remote areas of Southeast Asia, expectant mothers and patients traditionally needed to travel by boat to reach the regional hospital, which often put their lives at risk. The emergence of handheld scanners is transforming this situation.

Smarter Triage

Processing a large volume of patients and identifying who needs urgent care is another major challenge. In regional clinics with limited resources and a large number of patients, traditional triaging methods can be slow and exhausting for the workforce. Bot MD and Halodoc have emerged as solutions to this challenge. Bot MD is AI-powered, providing clinical assistance and a platform for patient engagement. It is specifically designed to assist hospitals and health care workers in automating workflow and remote monitoring.

AI-integrated health care in Southeast Asia is enhanced with the emergence of platforms such as Halodoc. Halodoc is an Indonesian platform that provides digital health care services. It allows patients to access specialists and doctors round the clock through calls, text messages and video consultations. It also allows users to order prescribed medicines and health care products. Options for booking laboratory tests are also available. It is improving health care access across Indonesia’s 17,000 islands.

Optimizing the Sparse Medical Workforce

These AI-integrated health care technologies in Southeast Asia also aim at workforce optimization. In remote areas where few doctors might be handling an entire island, their time becomes extremely valuable. When AI-integrated health care technologies handle language translation, preliminary documentation and baseline image analysis, they effectively reduce the burden on doctors.

Health care workers and volunteers can conduct initial screenings and save the information. AI-powered triage systems can then identify and alert health care professionals about severe cases. Therefore, doctors are not required to focus on routine administrative intake procedures or easily treatable cases. Instead, they can devote their time and energy to high-risk patients who require immediate, complex clinical intervention. AI-integrated health care in Southeast Asia serves as a solution to these challenges of isolated and remote islands.

Conclusion

The digital health care revolution is transforming health care dynamics in Southeast Asia. It demonstrates that it does not always take massive concrete infrastructure to overcome health care challenges; equitable health care can be achieved through small, handheld AI-powered devices. Technologies such as Halodoc, Bot MD and pocket ultrasound systems are helping to bridge the health care gap. AI-powered health care in Southeast Asia is successfully improving patient treatment and access to care.

– Noor Ul Ain Ameer

Noor is based in Islamabad, Pakistan and focuses on Technology and Solutions for The Borgen Project.

Photo: Flickr

 

,

Nations Unite on a Historic WHO Pandemic Agreement

WHO Pandemic AgreementOn May 20, 2025, diplomats from around the world voted almost unanimously in favor of the world’s first legally binding WHO Pandemic Agreement, in response to one of the most glaring failures of COVID-19.

This failure was in stark contrast to high-income versus low-income countries during the pandemic. By November of 2023, vaccination coverage in some countries was below one-third, compared to the four-fifths of residents vaccinated in many high-income nations. Legal barriers such as patent waivers for vaccines were dismantled, yet doses still never reached the countries that needed them because of manufacturing capacity issues. One African manufacturer secured the ability to produce a vaccine, but its production lines sat idle because no African governments placed any orders.  In short, the system was broken. The Pandemic Agreement was the world’s attempt to fix it.

How the WHO Pandemic Agreement Came to Be

The World Health Assembly session launched the process in December 2021, as the Omicron variant was spreading globally and wealthy nations sat on stockpiles of doses the rest of the world could not access. The Intergovernmental Negotiating Body that followed held 13 formal rounds of talks along with countless informal sessions. Negotiators overcame walkouts, last-minute standoffs and a hostile political environment, including open rejection from some political leaders as well as pressure from the private sector.

What the Pandemic Agreement Does

Critical ideas that had no legal definition during COVID-19, such as One Health or equity, now have standing in international law, offering governments a stable framework for future pandemic response, according to a J Law Med Ethics article.

At the heart of the deal is a pathogen access and benefit-sharing system (PABS). Under this mechanism, countries agree to share genetic sequence data about circulating pathogens with WHO. In return, pharmaceutical manufacturers who participate commit to making 20% of their real-time production of pandemic vaccines, therapeutics and diagnostics available to WHO, with at least half of it being donations and the rest at affordable, realistic prices, according to PAHO. To put that in concrete terms, if a manufacturer makes 10 billion vaccines, around 2 billion will flow to WHO for distribution based on public health needs, particularly to developing countries.

Formal Emergency

The agreement directly links the PABS system to a formal pandemic emergency declaration under the International Health Regulations, making redistribution automatic rather than dependent on the goodwill of individual actors, according to a J Law Med Ethics article.

Beyond access to vaccines, the agreement takes a broader view of what pandemic preparedness means. It incorporates a One Health approach by recognising that around 75% of emerging infectious diseases originate in animals, so it requires countries to have surveillance systems linking human, animal, and environmental data, according to the WHO. A Global Supply Chain and Logistics Network will address gaps in medical supply chains before the next crisis. Plus, for the first time, the protection of health workers during pandemic emergencies is enshrined as an international legal obligation.

A Foundation for a Fairer Future

During COVID-19, the problem was not only a shortage of doses but also of capacity. Article 11 of the agreement pushes beyond the patent waiver model and calls on technology-holders to share know-how, skills, and proprietary information through WHO-led hubs to build genuine manufacturing capability across the Global South.

The agreement still requires work. A critical annex detailing the operational specifics of the PABS system still requires adoption at the 79th World Health Assembly in May 2026, and ratification by at least 60 countries is necessary before the WHO Pandemic Agreement enters into force. But for the first time, the architecture exists. Equity is now a legal obligation, agreed upon by the overwhelming majority of the world’s nations.

– Gia Sen

Gia is based in Mansfield, MA, USA and focuses on Business and Politics for The Borgen Project.

Photo: Flickr

,

PERi-Farms: Nando’s Supporting Smallholder Farmers

PERi-FarmsCountries in Southern Africa, including Zambia, Malawi, Mozambique and Madagascar, continue to face extreme poverty, with limited progress in recent years. About 71% of the population in Zambia, 81% in Mozambique and 69% in Madagascar live on less than $3.00 a day, while 70% of the population in Malawi lives on less than $2.15 a day. In addition, a significant share of the population across the region experiences severe malnutrition and insufficient caloric intake.

In Southern Africa, agriculture remains central to both livelihoods and economic growth, with 60% of the population depending on the sector for income and survival. Yet the region continues to face severe malnutrition, exposing a deep contradiction between reliance on agriculture and persistent food insecurity. Farmers across the region face major barriers, including limited access to technology, climate shocks and chronic food insecurity. 

These challenges make it difficult for farming households to move beyond the poverty line or earn enough to sustain themselves and their families, reinforcing a cycle of intergenerational poverty.

Nando’s PERi-Farms

In response to the challenges Southern African farmers face in earning a sustainable living, Nando’s launched a scheme to promote sustainable farming. Recognizing the region’s heavy dependence on agriculture, the company identified an opportunity to help improve the quality of life for smallholder farmers by addressing the setback created by limited resources and low incomes.

In 2012, Nandos committed to supporting smallholder farms in Southern Africa by buying chilies from farmers in Mozambique, Malawi, Zimbabwe and South Africa for use in its well-known PERi-PERi sauces. What began with just six farmers, who supplied 1.6% of Nando’s chili requirements at the time, has since grown to more than 1,400 farmers across 18 growing regions in those four countries.

Through this model, Nando’s provides smallholder farmers with a more stable income throughout the season. This stability helps protect farmers from price fluctuations driven by crop quality, climate-related disruptions and early-season pricing pressures. Regional farming organizations run the project on Nando’s behalf. 

They teach smallholder farmers in Southern Africa more sustainable farming practices and provide them with finance, materials and seedlings that they may have found hard to obtain. As a result, findings from the Impact Amplifier show that, compared with national averages in their respective countries, farmers in Nando’s supply chain are 95% more food secure, 75% more energy secure and achieve 80% higher completion rates across primary, secondary and tertiary education.

How This Makes a Difference

The Impact Amplifier has strengthened Nando’s capacity in areas such as professional development, food security, health care and education. This has enabled the company to better support independent smallholder farmers in Southern Africa. It does so by improving access to finance and agricultural inputs, providing training in efficient farming practices and offering more stable pricing throughout the growing season.

This means that smallholder farmers in Southern Africa can afford to educate their children, expand their homes, access solar power and grow their livestock herds. In turn, this helps families build more secure futures and gradually break the cycle of poverty.

Future Initiatives 

With the success of the PERi-Farms program, Nando’s has expanded its support beyond the well-known African Bird’s Eye chilies to other crop-growing areas. The scheme now also includes crops such as paprika and cayenne pepper, both key ingredients in Nando’s famous PERi-PERi sauce. This expansion is expected to increase income opportunities and extend support to more smallholder farmers.

Nando’s support for smallholder farmers also promotes gender inclusion, creating opportunities for women through female-focused farming initiatives. Ciara Carpenter, a former intern at Nando’s Malaysia, explained in an interview with The Borgen Project: “They allow women to work on the farms and they provide some form of education and teaching to enable them to progress and grow so they can get other jobs.”

Through this approach, Nando’s enables women to build independence, expand their economic opportunities and better support their families, contributing to more resilient livelihoods.

Final Remarks

“It is nice to understand how some companies are incorporating CSR and sustainability practices into their operations. The Nando’s chili farm not only farms chili but also supports education and helps women get jobs. The farms teach their farmers so that they can then progress onto new things,” Carpenter said as a closing remark in an interview with The Borgen Project.

Through its efforts to help address global poverty, Nando’s has improved the quality of life for smallholder farmers in Southern Africa. The company’s scheme has helped farming families gain access to more stable incomes, better education, improved housing conditions and greater knowledge of sustainable, long-term agricultural practices. In an interview with The Borgen Project, Ciara Carpenter also highlighted the equal opportunities Nando’s creates for women. She explained how Nando’s Malaysia contributes to the company’s wider commitment to sustainable sourcing.

– Freya Bryers

Freya is based in Surrey, UK and focuses on Good News and Technology for The Borgen Project.

Photo: Flickr

,

Molbio Diagnostics: Improving Health Care in South Asia

Molbio DiagnosticsMolbio Diagnostics is a point-of-care diagnostics company which strives to expand access to disease detection for infectious and non-communicable diseases. By bringing accurate, lab-quality testing directly to underserved communities, the company is helping ensure earlier treatment and reducing the spread of infectious disease in countries like India, Bangladesh and Cambodia, improving the accessibility of health care in South Asia.

Truenat

Its leading product, Truenat, is a portable testing platform, which carries out the diagnosis of illnesses like tuberculosis in remote areas. Since its launch, it has become one of two rapid molecular diagnostic platforms that the World Health Organization (WHO) endorsed for tuberculosis and rifampicin resistance detection and is operating in several countries right now. In particular, in India, 7,700 Truenat devices have conducted more than 30 million tests since 2021, making it the core of their National TB Elimination Program.

The greatest strength of the truant devices is their efficiency; they can test patients and administer treatment in a single day, something which has revolutionized disease transmission in resource-scarce areas. Families no longer have to save up to make multiple trips to testing sites or have to wait weeks before receiving treatment, immensely improving their chance of a cure.

For example, in Bangladesh in 2022, medical staff tested 59,000 people and found 58 of them to have drug-resistant tuberculosis, meaning they would have received the incorrect treatment if they had not been able to use the Truenat devices. Therefore, these devices have revolutionized the accessibility of health care in South Asia, allowing people from remote areas to receive diagnosis and treatment more efficiently than ever before.

Other developments

Whilst Truenat is the most used and recognized technology developed by Molbio Diagnostics, it has also developed other technologies with the same goal of improving the accessibility of health care in South Asia. For example, Prorad Atlas is a portable X-ray machine, weighing less than 3 kilograms with a fully rechargeable battery and iBreastExam is a portable breast exam machine, which has helped test more than 1.5 million women world wide for breast cancer.

Most importantly, Molbio Diagnostics put their technology and expertise to work during the COVID-19 pandemic; some features of the Truenat devices were tweaked to enable them to test for COVID-19. The Indian government approved this, allowing more than 800 sites to begin testing, something which was especially necessary in transit hubs and along borders.

Since its launch, Molbio Diagnostics has led the way in global efforts to make health care more accessible, bridging the gap between urban and rural areas across South Asia. These technologies have not only cured thousands, but they have also instilled hope in historically resource-scarce areas for the future of their health care.

– Vittoria Cortese

Vittoria is based in Washington DC, US and focuses on Technology and Solutions for The Borgen Project.

Photo: Wikimedia Commons

,

Elimination of Leprosy in Chile

Leprosy in ChileAfter decades of hard work and effort, officials in the South American country of Chile have seen a substantial decrease of the potentially dangerous chronic infection, leprosy. As of March 2026, Chile became the first ever country in the Americas to eliminate the leprosy disease from inside its borders. A stunning milestone within the wide world of medicine and yet in order to apply the resources of Chile’s success directly into other viruses, it is important to understand exactly what measures are necessary to prevent the spread of the virus and to enforce leprosy eradication.

Background

Leprosy is a chronic, bacterial infection caused by the ingestion of a specific type of bacteria “Mycobacterium leprae.” Once the virus enters its host’s body, it quickly gets to work infecting the body’s skin and nerves, causing immense physical pain and discomfort to its victims. While the infection is not believed to be fatal, leprosy disease can cause various uncomfortable conditions, including severe itching, muscle fatigue, nerve weakness, and, without adequate recognition and treatment, serious disabilities. While treatment for leprosy eradication is available to those who seek it, it is challenging for victims to pursue a cure, as leprosy disease is difficult to properly identify, and symptoms don’t typically show themselves until years after the infection.

Hope is Still There

While leprosy is a dangerous disease that can leave potentially life-altering side effects, thankfully, hope is still there as there are a handful of treatments that can help with leprosy eradication in the body.

As of early March, both the World Health Organization (WHO) and the Pan American Health Organization (PAHO) have officially verified that Chile has not recorded leprosy for as long as 30 years. While this landmark accomplishment deserves celebration, it’s important to consider that leprosy eradication in Chile not only luck, but rather a set of principles Chile has taken to reduce the spread of leprosy.

A common example includes increased surveillance around the country, intended to closely monitor and detect sicknesses as soon as they come up and treat them accordingly, rather than choosing to wait and risk harmful side effects. Those who are found infected are treated and followed up on for the disease immediately. WHO has implemented a strategic system in place which ensures that anyone who is diagnosed with leprosy receives continuous, long-term health benefits to help aid the recovery process.

Multidrug Therapy

Another important discovery that has led to complete leprosy reduction in Chile is the expanded access that patients now have to multidrug therapy (MDT), a combination of medications used to thoroughly treat leprosy. Both PAHO and WHO have cooperated to pledge their support for the implementation of the MDT method within the Americas, completely free of charge to all of its members. The frequent generosity of donors around the world has made it possible to more effectively identify the disease before it negatively impacts its respective hosts and then cure the disease, effectively reducing leprosy before it takes control.

Chile’s new methods of disease recognition have been successful in allowing for Leprosy eradication within the entire country’s border. Efforts by the WHO and PAHO organizations have paved the way for more positive treatment for disease, including increased surveillance systems to track and monitor viruses and the MDT program, which have been consistently successful as shown by the grand milestone.

The decades of time and effort spent into eradicating the leprosy virus in Chile have finally paid off, and it goes to demonstrate that threatening diseases that may at first seem impossible to truly erase are actually quite easy when governments commit to certain health strategies, as cooperation is essential for not only the elimination of viruses within certain countries, but also as a way to maintain their absence in the following years.

– Will Mancuso

Will is based in Lake Mary, FL, USA and focuses on Good News and Technology for The Borgen Project.

Photo: Flickr

, ,

The Durban Promise for African Health Sovereignty

durban promiseMany people in Africa cannot get the care or medicines they need, or they must pay for treatments themselves, causing nearly 11 million low-income Africans to fall into poverty every year. Determined to rectify this inequitable situation, participants at the 2025 Conference on Public Health held in Durban, South Africa, endorsed a pledge stating that Africa will begin to manufacture, regulate, and procure its medical items internally. Known as The Durban Promise for African health sovereignty, the assertion aims to promote health care equity by lowering costs and creating millions of jobs for its citizens, helping to alleviate poverty and provide universal health coverage to all Africans.

The Need for African Health Sovereignty

Africa currently imports about 70% of its medicines, 90% of its medical devices, and 99% of its vaccines. This drives up costs and limits medical treatment accessibility for many Africans. Adding more urgency to the situation, global health funding in Africa has declined 70% since 2021. Significant cuts to the USAID and reduced contributions from European donors seemed to make universal health care coverage (UHC) for Africa even less attainable.

However, African leaders anticipated the reductions and were actively seeking alternative sources of health care subsidies. As a result, China pledged $50 billion to support Africa’s health care program, funding that has accelerated the building of hospitals and clinics. Indeed, with significant financing, the Durban Promise is on the way to becoming a reality, bringing universal health care coverage within reach.

The Road to UHC

African governments have been working towards universal health care coverage for more than 20 years, but have faced significant obstacles. The Abuja Declaration of 2021 asserted that 15% of African national budgets should be allocated for health care, though many African countries still spend less than half that amount in the medical arena.

In 2023, African leaders signed The Lusaka Agenda, compelling governments to meet Abuja obligations and to implement actions that would lower the cost of medicine. However, this agenda was not fully successful due to challenges with domestic financing. With minimal results from these initial affirmations, in October 2025, African governments signed The Durban Promise, a roadmap for African health sovereignty and security that suggests an innovative medical financing structure to move Africa’s health care goals forward.

The 2025 G20 Summit

The annual G20 summit, which the African Union joined in 2023, brings together developed and emerging economies to address urgent global issues. The 2025 summit, held in Johannesburg, South Africa, marked the first time the assembly met on African terrain. The agenda from the South Africa’s President Cyril Ramaphosa discussed the challenges of developing nations, which include the pressing issue of health insecurity. Ramaphosa’s compelling arguments led to increased funding from the World Health Organization and a Global Health Security Pact for equitable vaccines and sharing of data during global health emergencies. The pact further addresses African health security and the goals of the Durban Promise.

The Presidential Declaration

At the 39th African Union Summit in Addis Ababa, Ethiopia, in February 2026, countries made the commitment of the Durban Promise, according to AfricaCDC. The Presidential Declaration on Advancing Local Manufacturing of Health Products in Africa was issued with the objective that the African continent will produce 60% of medical products internally by 2040. The declaration includes two key strategies led by the African Center for Disease Control (CDC) focusing on securing the goal of health autonomy: The Platform for Harmonized African Health Products Manufacturing (PHAHM) and The African Pooled Procurement Mechanism (APPM).

By creating a single health product market, the PHAHM will help align regulatory and manufacturing policies across the African Union. The APPM could enable African countries to leverage their joint bargaining power to make the market more predictable and desirable for suppliers, leading to supply security. Together, these approaches can help African health care to thrive.

Outlook for African Medical Sovereignty

There is much to do in order to achieve the goal of producing 60% of medical products on the African continent in less than 15 years. As daunting a task as it may be, with a thoughtful, well-executed plan and targeted efforts, the result can be a robust health program that will contribute to regional income and poverty reduction as articulated in The Durban Promise.

– Debbie Barto

Debbie is based in Monroe, WA, USA and focuses on Technology and Global Health for The Borgen Project.

Photo: Flickr

, ,

How Maternal Health Programs Reduce Mortality Rates in Benin

Mortality Rates in BeninAccording to the World Health Organization (WHO), Benin has a maternal mortality ratio of 518 deaths per 100,000 live births, meaning hundreds of women die each year from preventable pregnancy-related complications. Common causes include blood loss, infection, high blood pressure, insufficient post-partum care and even financial limitations. 

These causes highlight the role of maternal health programs in reducing maternal mortality rates in Benin by offering assistance, care and education. These services improve survival rates, reduce long-term health complications and strengthen families and communities. Several international organizations are actively working to reduce maternal mortality rates in Benin.

Médecins Sans Frontières

Médecins Sans Frontières (MSF), also known as Doctors Without Borders, partners with the Benin Ministry of Health (MOH) to support activities in villages that promote pregnancy education and awareness, consultations and access to contraceptives. MSF has also assisted several health centers by supporting staff recruitment, improving working conditions and supplying essential medical equipment and medicines. 

In addition, MSF has supported more than 9,920 people with safe deliveries, assisted 3,253 people with family counseling and conducted more than 22,211 prenatal consultations. These efforts directly reduce preventable maternal deaths by ensuring that women have access to skilled medical professionals, safe delivery environments and essential reproductive health services. By expanding access to skilled care, MSF plays a key role in reducing maternal mortality rates in Benin.

UNFPA

Another organization working to improve maternal health in Benin is the United Nations Population Fund (UNFPA). UNFPA is an international reproductive health agency of the U.N. that operates in more than 150 countries. Its mission is “to deliver a world where every pregnancy is wanted, every childbirth is safe and every young person’s potential is fulfilled.” 

UNFPA also addresses the “three delays” in maternal health: deciding to seek care, reaching a health facility and receiving adequate treatment. During its previous program cycle in Benin, UNFPA reached more than 985,944 new modern contraceptive users, prevented more than 290,296 unintended pregnancies and educated more than 809,820 adolescents and youth about reproductive health. By addressing both medical barriers and social obstacles, such as education and access to contraception, UNFPA helps prevent high-risk pregnancies and long-term complications, lowering maternal mortality rates in Benin.

Benin Mamas

Benin Mamas is a local nonprofit organization supporting maternal health through programs such as the Safe Motherhood Initiative, Mental Health and Postpartum Support, Smart Starts: Saying No to Teen Pregnancies and Mamas Speak Up. Through empowerment programs, educational workshops and targeted interventions, Benin Mamas expands access to maternal health care across rural and underserved communities.

Final Remarks

Together, these three initiatives demonstrate how maternal health programs support underserved and rural communities by filling gaps in government services and expanding access to essential care. By strengthening reproductive health services and promoting education, MSF, UNFPA and Benin Mamas help reduce maternal mortality rates in Benin and build a more sustainable future for families.

– Bianca P. Gunawan

Bianca is based in Jakarta, Indonesia and focuses on Good News and Global Health for The Borgen Project.

Photo: Flickr

, ,

How Mobile Clinics Are Expanding Dental Care in Rural Bolivia

Dental Care in Rural BoliviaLimited access to dental care is an often overlooked public health challenge in rural Bolivia, particularly for low-income and geographically isolated communities. Untreated tooth decay and gum disease can lead to chronic pain and infection, making it harder for children to concentrate in school and for adults to work consistently. In a country where household budgets are often tight, delaying care can also lead to higher costs later, especially when treatable problems become emergencies. Mobile dental clinics are one approach to helping close these gaps by bringing preventive and basic restorative services directly to underserved communities.

Why Dental Care Is Difficult To Access in Rural Bolivia 

Bolivia’s geography and settlement patterns create real barriers to routine care. Rural communities may be located far from clinics, with travel costs and time away from work making a dental visit impractical. Where dental services exist, they may be limited to urgent pain relief or extractions rather than preventive treatment or restorations. 

At the national level, the WHO’s Oral Health Profile for Bolivia highlights the economic impact of oral disease. It estimates per-capita spending on dental care at approximately $4.20 and productivity losses from five untreated oral diseases at $152 million. This is an indicator of how oral health problems can translate into missed work and reduced earning capacity. 

What Mobile Dental Clinics Do Differently

Mobile dental clinics reduce access barriers by bringing equipment and staff directly to remote areas, often in coordination with local schools and community authorities. Depending on the program, services may include examinations, cleanings, fluoride applications, sealants, basic restorations (fillings) and extractions, along with hygiene education. This approach is important because it shifts care upstream, preventing decay and addressing early-stage problems before they develop into infections that require more complex interventions.

Evidence From Mobile-Clinic Programs Operating in Rural Bolivia

One example of measurable outcomes comes from the Suyana Foundation. It operates mobile dental clinics in the Department of La Paz and tracks multi-year data on service delivery and oral health indicators in the communities it serves. In a program summary covering Bolivia, Suyana reports that between 2021 and 2023, its mobile dental clinics provided approximately 38,000 dental consultations. 

Over the same period, the foundation recorded improvements in standard oral health indices. These included a 21% drop in the CPOD/DMFT index (from 6.7 in 2021 to 5.3 in 2023) and a 44% reduction in the simplified oral hygiene index (IHOS) (from 2.5 in 2021 to 1.4 in 2023). Suyana also reports child-focused results: the incidence of new caries among 10-year-old children fell by 38% from 2022 to 2023 in its Bolivian program. 

Additionally, the number of students rehabilitated to “zero cavities” status increased from 296 in 2021 to 1,229 in 2023. These figures reflect the impact of a single organization rather than the entire country; however, they provide concrete evidence that mobile, prevention-oriented dental services can improve outcomes in areas with limited baseline access.

How Public Nonprofit Partnerships Expand Reach

Mobile-clinic models often depend on partnerships because logistics and sustainability are as important as clinical work. Public authorities can support coordination with schools, referral pathways into local health establishments and alignment with national standards. Nonprofits can add specialized staff, equipment, outreach capacity and external funding.

In Bolivia’s health ecosystem, organizations like Fundación ProSalud have a national presence, providing lower-cost health services through a network of clinics. These clinics help complement public provision and support broader access goals. Volunteer-based outreach models also operate in rural areas. 

In Cochabamba and surrounding regions, the nonprofit Mano a Mano runs “jornadas”—weekend medical and dental trips where teams travel to remote communities to provide care. This shows how mobile or pop-up services can reach areas that permanent facilities do not consistently cover.

Why Dental Access Matters for Poverty Reduction

Dental care can look “secondary” compared to infectious disease or maternal health, but it has direct poverty links. Pain and infection can reduce school attendance and workplace productivity, while delayed treatment can force families into higher-cost emergency care. The WHO’s estimates of productivity losses from untreated oral diseases underline that oral health is not only a clinical issue but also an economic one, especially for households living close to the margin.

Mobile dental clinics address this problem by reducing the time and travel costs of seeking care and emphasizing prevention. When clinics provide sealants, fluoride and early restorations, they can reduce the likelihood that a child needs repeated extractions or that an adult loses workdays due to avoidable infection.

The Future of Dental Care in Rural Bolivia

Mobile clinics are not a substitute for long-term investment in permanent facilities and the oral-health workforce. But in rural Bolivia, they can function as a practical bridge, expanding coverage now while building community habits around preventive care. Evidence from programs such as Suyana’s mobile clinics suggests that sustained outreach can improve measurable oral-health outcomes, particularly for children. 

As government standards, local coordination and nonprofit delivery capacity align, mobile dental services can continue reducing preventable pain, missed school days and productivity losses in underserved regions. 

– Tom Basu

Tom is based in Buckinghamshire, UK and focuses on Good News and Global Health for The Borgen Project.

Photo: Flickr

, ,

Nanozymes hold promise for developing countries

NanozymesNano enzymes (nanozymes) are an emerging technology that could transform the fields of disease diagnosis, environmental remediation and food safety. Made from nano materials, nanozymes can mimic the functions of natural enzymes while exhibiting enhanced optical, electrical and chemical properties. Due to their low cost, high stability and ease of mass production, nanozymes hold promise for developing countries as they have the potential to provide affordable, accessible healthcare solutions to those living in poverty.

What are Nanozymes

Nanozymes are processed from various types of nanomaterials and must be biodegradable and biocompatible as they are used in living and environmental systems. Their synthetic nature makes them highly stable, unlike natural enzymes that degrade, enabling reliable mass production with standard techniques such as chemical reduction. Nanozymes are generally classified into four groups: metallic-based, metal oxide-based, carbon-based, and others (such as metal-organic frameworks).

Nanozymes possess numerous properties that make them extremely valuable, with different types of nanozymes exhibiting unique attributes and capabilities. Noble metal- (e.g. silver and gold) based nanozymes possess antibacterial activity, providing the ability to treat infectious illness. Metal- and carbon-based nanozymes exhibit antioxidant properties and have the potential to treat neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s as well as other conditions such as cancer and kidney disease.

Due to their high catalytic activity, metal, metal-oxide and carbon-based nanozymes can function as biosensors, aiding in detection of cancer, viruses and food-borne pathogens and can also be used to treat environmental pollution due to their bioactive nature. Metal-organic nanozymes, with high porosity and catalytic activity, can also be used for environmental remediation.

Diagnosis of Ebola

The Ebola virus is one of the world’s deadliest viruses. Without treatment, up to 90% of cases are fatal. From 2014 to 2016, West Africa experienced the largest ever Ebola outbreak with more than 28,600 people infected. Due to vaccines and early isolation, the number of new Ebola cases has since decreased considerably, though innovative detection solutions could potentially reduce the rate even more. A new method that could even more rapidly detect the virus uses an MNP-based immunochromatographic strip capable of identifying the Ebola virus glycoprotein. The proposed strip provides results quickly and is simpler to use than the standard test strip, as it does not require specialized facilities and people can read it with the naked eye. With a sensitivity of more than 100 times that of standard tests, the anticipated nanozyme strip could have great benefits for Ebola diagnosis.

Nanozymes for Treatment Of Water

Industrial production can discharge high concentrations of chemicals into wastewater. This can lead to environmental pollution and human health issues without proper treatment. Traditional biochemical water treatment techniques can be inefficient in degrading wastewater chemicals, while nanozymes are capable of efficiently oxidizing chemicals and eliminating them from the wastewater. Nanozymes are just beginning to enter the water treatment market space and are another way in which nanozymes hold promise for developing countries.

Food Microbe Detection

Foodborne microbes such as Listeria and Salmonella can cause sickness and even death. The risk of foodborne illness is highest in low- and middle-income countries due to inadequate food storage conditions, poor preparation practices and lack of food safety laws.

Traditional food microbial detection techniques can be time-consuming, requiring several processing steps, while food microbe biosensing nanozymes can detect microbial contaminants in food more efficiently with high accuracy, according to Biomimetics.

Swift detection of food contaminants can halt the provocation of foodborne illness and reduce the monetary burden on individuals. Affordable food microbial-sensing nanozymes are currently on the market and can provide great benefits to those in developing countries who have minimal economic resources.

Shown to increase the speed and efficiency of key health-related activities such as disease diagnosis, food safety monitoring and environmental treatment processes, nanozymes hold promise for developing countries that could greatly benefit from their low cost, straight forward production process and their fast-acting capabilities.

– Debbie Barto

Debbie is based in Monroe, WA, USA and focuses on Technology and Solutions for The Borgen Project.

Photo: Flickr

, ,

Healing the River: Schistosomiasis in São Tomé and Príncipe

Fighting Schistosomiasis in São Tomé and PríncipeSchistosomiasis or bilharzia thrives where people lack safe water and sanitation. Schistosomiasis remains endemic in São Tomé and Príncipe, primarily caused by Schistosoma intercalatum. The World Health Organization (WHO) classifies the country as requiring preventive chemotherapy, indicating ongoing transmission. Despite multiple rounds of mass drug administration, the disease persists in certain communities, particularly near streams and rice fields, where children remain at risk. Ongoing surveillance is essential to monitor and address localized transmission hotspots.

A Low-Level but Stubborn Threat

Recent studies confirm that São Tomé and Príncipe maintains a low but persistent level of schistosomiasis transmission, primarily caused by Schistosoma intercalatum. According to research published in PLOS Neglected Tropical Diseases in 2023, national prevalence remains low following repeated rounds of mass drug administration and health education campaigns. Ongoing surveillance continues to identify limited transmission in certain communities, underscoring the need for sustained control measures under World Health Organization guidance.

Momentum Since 2014

After a nationwide mapping survey in 2014, the Ministry of Health launched preventive chemotherapy with praziquantel in schools. In 2015 alone, more than 31,000 school-age children received treatment—an essential step to cut infections and protect those most at risk. Continued surveillance has turned up only sporadic cases, including a rare neuroschistosomiasis report in 2020, underscoring why vigilance still matters even as prevalence drops.

A 2024 Milestone: Halting Mass Drug Administration

Regional partners now point to a major achievement. The WHO Africa region’s ESPEN program reported in its 2024 annual review that São Tomé and Príncipe halted mass drug administration (MDA) in all endemic implementation units, marking a key waypoint toward elimination. ESPEN’s 2025 data updates also list STP among countries that did not conduct MDA in 2024, consistent with a transition from blanket treatment to targeted surveillance and response.

Water, Sanitation and Hygiene: The Long Game

Treatment alone cannot finish the job. Lasting gains depend on safe water, sanitation and hygiene (WASH) so people aren’t re-exposed to rivers and irrigation canals. UNICEF reports recent WASH actions in STP, including strengthening handwashing behaviours and coordinating a multisectoral WASH platform—efforts that protect families from schistosomiasis and other infections. Global JMP updates from WHO/UNICEF show why this matters: many health facilities and households worldwide still lack basic WASH services, a gap that sustains NTD transmission.

What’s Needed Next

São Tomé and Príncipe continue national efforts aligned with World Health Organization (WHO) guidance to control schistosomiasis. Current work includes post–mass drug administration monitoring, integrating surveillance into primary health care and coordinating with education and water agencies to sustain prevention gains. The Ministry of Health, with support from WHO and international partners, maintains praziquantel distribution in areas where transmission remains and tracks infection data to guide control strategies. These ongoing initiatives reflect the country’s commitment to meeting the WHO’s 2030 targets for neglected tropical diseases.

Why it Matters

Eliminating schistosomiasis saves children from anaemia, abdominal pain and missed classes, and it strengthens primary health care. With MDA paused and WASH investments growing, São Tomé and Príncipe has a real shot at stopping transmission. Sustained funding for surveillance and water infrastructure can help the islands turn a quiet success into a permanent victory.

– Katie Williams

Katie is based in the United Kingdom and focuses on Global Health for The Borgen Project.

Photo: Flickr